Packaging

Improving Patient Compliance via Packaging and Labelling

Improving Patient Compliance via Packaging and Labelling

Patients rely on the information provided on a product to instruct them in a manner which will lead to safe and effective use. Therefore any flout in accuracy could have fatal consequences. In this top tips eBooK on improving patient compliance via packaging and labelling, we spoke with packaging specialist Karel van der Waarde about the the strategies used to enhance compliance with patients to help them follow the therapy plan more effectively.
Combatting Malicious Tampering in Pharma: The Weakspots

Combatting Malicious Tampering in Pharma: The Weakspots

This infographic assesses the top anti-tamper weaknesses experienced within pharmaceutical packaging and labelling.
Pharmaceutical Packaging & Labelling Strategy Insights

Pharmaceutical Packaging & Labelling Strategy Insights

As pharmaceuticals come under greater regulatory scrutiny, companies have to evaluate their packaging and labelling processes to ensure compliance and reduce risk. We spoke with key opinion leaders from the industry to reveal the biggest obstacles they face in achieving excellence and reveal their top tips for an effective packaging and labelling strategy and process.
Engagement, Automation & Simplification: 3 Steps to Optimising your Packaging Line

Engagement, Automation & Simplification: 3 Steps to Optimising your Packaging Line

In this Pharma IQ interview Gianluca Fioravanti, Head of Packaging and Warehouse Operations, GlaxoSmithKline, shares his top tips for achieving overall equipment performance, optimising packaging lines and overcoming complexity within the packaging process.
Falsification and Pharmacovigilance: What Do Patients Get to See and What Should They Do with It?

Falsification and Pharmacovigilance: What Do Patients Get to See and What Should They Do with It?

The ‘Falsified medicines directive’ (2011/62/EU) and the ‘Pharmacovigilance regulation’ (No 1235/2010) will influence some of the information that patients receive about medicines. In both the directive and the regulation, several forms of visual communication are mentioned.

In this discussion piece Dr Karel van der Waarde explores the impact of the latest falsification and pharmacovigilance regulation on pharmaceutical packaging.

Top 20 Packaging Complexity Management Tips

Top 20 Packaging Complexity Management Tips

Discover Top 20 things to consider to drive the maximum value out of your pharmaceutical packaging portfolio. This booklet takes the popular Top 20 Tips format to describe key features of a complexity management capability in an easy to digest format.
Tamper Evidence in Pharma Packaging - Expert Insight eBook

Tamper Evidence in Pharma Packaging - Expert Insight eBook

The anti-counterfeit packaging market is forecasted to reach US$206.57 billion by 2021, just shy of doubling its 2016 figure of $107.26 bn. This growth is supported by the expanding pharma and food and beverage industries, with Asia Pacific set to take the largest market share. China is earmarked to lead the way in 2021 with its drive in manufacturing activities fueling that lead.

The anti-tampering market is littered with challenges to address: meeting EU FMD requirements, satisfying country specific requirements, preserving patient usability and not to mention outwitting resourceful counterfeiters. In this ebook we look at the road to meeting the 2019 FMD deadline, finding the most suitable anti tamper evidence feature as well as patient compliance and future trends in the industry.

Insight from:

Dieter Mößner
Edelmann GmbH/ Convenor of ISO TC 122 WG 15 “Tamper Verification Features on medicinal product packaging

Horst Kastrup
Senior RegulatoryAdvisor
MEDA Pharma